Grants per year
Search results
-
Active
Prot #M19-044: A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, and Tolerability of Upadacitinib in Adult and Adolescent Subjects with Non-Segmental Vitiligo Who Are Eligible for Systemic Therapy
Kundu, R. V. (PD/PI)
6/27/24 → 6/27/27
Project: Research project